(Q47894248)

6 February 2018

title

Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses (English)

1 reference

6 February 2018

author name string

Trillat AC

1

1 reference

6 February 2018

Malagié I

2

1 reference

6 February 2018

Mathé-Allainmat M

3

1 reference

6 February 2018

Anmela MC

4

1 reference

6 February 2018

Jacquot C

5

1 reference

6 February 2018

Langlois M

6

1 reference

6 February 2018

Gardier AM

7

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

6 February 2018

European Journal of Pharmacology

published in

1 reference

6 February 2018

volume

347

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

41-49

1 reference

6 February 2018

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

8-OH-DPAT attenuates the dexfenfluramine-induced increase in extracellular serotonin: an in vivo dialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

(S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Blockade of the central 5-HT autoreceptor by beta-adrenoceptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Pharmacological and physicochemical properties of pre-versus postsynaptic 5-hydroxytryptamine1A receptor binding sites in the rat brain: a quantitative autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

SDZ 216-525, a selective and potent 5-HT1A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

(-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900085-5

10.1016/S0014-2999(98)00085-5

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018